WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study
- PMID: 2841696
- DOI: 10.1055/s-2007-1014667
WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources